chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On April 2, I had intense fatigue starting around 8 PM. I took acetaminophen and went to sleep. On April 3, I woke up with intense body ache around 8 AM. I took acetaminophen throughout the day. In the afternoon, I developed a low-grade fever that reduced with acetaminophen. On April 4, I woke up at 6 AM with diarrhea. I proceeded to have a bout of diarrhea 20 minutes later. Soon after, I vomited. The vomiting and diarrhea continued throughout the day at a frequency of every 20 minutes until about 4 PM. An anti-diarrheal and Pepto did not help. I was very dehydrated but was able to rehydrate myself once the diarrhea and vomiting stopped. On April 5th, despite being adequately hydrated at that point,  I had a pounding headache that was not remedied by acetaminophen or ibuprofen. The headache lasted the whole day but was not present on April 6.
Tearful, tired, temperature, loss of appetite, unable to put pressure on his legs so unable to walk for 3 days. After 3 days he began to seem better. But 5 days later he began be unwell again, clingy, tired, fever. 7 days later he still had a loss of appetite then came out in a rash. Seemed to have an itchy head and possibly ear ache. After about 4 weeks he was more like his usual self.
This spontaneous report was received from registered nurse referring to a currently 11 year old male patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 21-SEP-2018, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N026073, expiration date: 20-SEP-2019 (additional dosage regimen information was not provided) for prophylaxis. It could not be further clarified if sterile diluent was stored appropriately. No adverse event was reported. The vaccine was exposed to multiple temperature excursions to -12.4 Celsius degrees for a timeframe of 4 hours and 30 minutes. It was found because of a digital data logger.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2013, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2015, the patient was treated for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Moderna COVID-19 Vaccine EUA  Chills,swollen lymph nodes on left arm, fatigue
Systemic: Dizziness / Lightheadness-Severe, Systemic: Hypotension-Medium, Systemic: Weakness-Medium
p/vax pt c/o sinus pressure & swelling around eyes;pt went to work but was sent home to rest & take DPH;pt returned to work next day;pt believed vaccine caused above sx;
Tight throat and chest tightness, 12.5mg Benadryl  PO provided
Chest pain started 2 days after the second dose of Pfizer vaccine.  Found to have myocarditis requiring admission.  Full recovery is expected.
Swollen lymph nodes in armpits Fever 102F Body aches Chills symptoms started ~12 hours after vaccination 2nd dose
(R) arm rx to GARDASIL, arm hot, swollen blister? Imm given 7/8/11 reaction on 7/9-10? - No tx given.
LEG CRAMPS; HARD TO WALK; ACHY HIPS; ACHY LEGS; This spontaneous report received from a patient concerned an 81 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1805031, expiry: 26-MAY-2021) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAR-2021, the subject experienced leg cramps. On 26-MAR-2021, the subject experienced hard to walk. On 26-MAR-2021, the subject experienced achy hips. On 26-MAR-2021, the subject experienced achy legs. Laboratory data (dates unspecified) included: Scan (NR: not provided) No blood clots, and X-ray (NR: not provided) No blood clots. The action taken with covid-19 vaccine  was not applicable. The patient was recovering from hard to walk, and had not recovered from achy legs, achy hips, and leg cramps. This report was non-serious.
Tight chest, shortness of breath, long & steady dull pangs for 3 weeks until I went to the Urgent Care for a diagnosis.  On April 5, 2021, I went from the urgent care to the ER to having a catheter inserted into my wrist at local hospital, because they thought I was having a heart attack. Turns out I have myocardial bridging of the left anterior descending (LAD) artery. I am not in pain, thankfully, but these symptoms persist. Are they being magnified by the vaccine? No one seems to know. What I do know is that since receiving the vaccine I feel this tightness in my chest and it's not going away.
Started with SOB about 10 min. p receiving vaccine. EMS gave pt. Benadryl, Epinephrine x1 and H2 blocker. Symptoms continued and pt was transported by EMS to ER. She received 2 more doses of Benadryl and was given prescriptions  for EpiPen,  Famotidine and Prednisone dosepack. was monitored at ER for 4 hrs and discharged
Shingles outbreak to left side of body 3-4 days after bivalent vaccine. Also severe abdominal pain 4-5 days post injection.
Injection site soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 at 10:00 as dose 1, single (Lot number: EN6198) at the age of 66 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Skin cancer (basal squamous)", start date: 2017 (ongoing), notes: 2/3 previous outpatient surgeries 1 recent radiation treatment,finally 20th treatment on 25Aug2022; "Prostate cancer", start date: Nov2019, stop date: Jan2020, notes: Surgical removal Jan2020; "Cholesterol" (ongoing); "Acid reflux" (ongoing). Concomitant medication(s) included: ATORVASTATIN oral taken for blood cholesterol (ongoing); OMEPRAZOLE oral taken for gastrooesophageal reflux disease (ongoing). The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Injection site soreness".  Additional Information: Prior Vaccinations (within 4 weeks) was reported as none.
Injection site pain Information has been received from a health professional concerning a female patient who on 22-DEC 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #651330/1048P). On 22-DEC-2005 the patient experienced an achy deep soreness in the injection arm. It was noted that this may have been her second vaccination with pneumococcal 23v polysaccharide vaccine. At the time of this report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Hives appeared on inner thighs then spread to chest, stomach, arms, legs, neck, back, and face over the course of 1 month
pt recv vax 11OCT98 & lt arm 13OCT @ noc devel pain, redness @ the site, hot to touch;no improvement as of 15OCT98;no fever;
12/27 woke up with pain in left armpit. Swelling increased throughout the day. Pain was manageable without medication, did hurt when swelling was palpated or I squeezed my left arm down to my side. Woke on 12/28 with same pain, does not appear to be further swelling, but hurts in my armpit to hold my arm above my head.
Patient denies fever or chills. Swelling of left arm above elbow to the shoulder. Initially 3" circle at affected area, redness, itching, swelling. Received Solumedrol injection 125mg. 10/17/02 Still itches; faded bruising yellow/green
fatigued; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   The patient's past medical history included shingles (had 30 years ago on face and it was incredibly painful).   On an unknown date, the patient received the 1st dose of Shingles vaccine and PNEUMONIA VACCINE. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the fatigue to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the first shingle shot and pneumonia vaccine and was very fatigued the next day. It was unknown if the reporter considered the fatigue to be related to Pneumonia vaccine. For tolerance to 2nd dose, refer case US2021AMR200706.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR200706:same reporter
Patient claims vaccine (FLUZONE HIGH DOSE) was given too low and not in the muscle. Her arm is black/blue/red raised and feels like a hematoma/lump below skin.
Had sore arm for one day; A spontaneous report was received from a consumer  concerning a 79year old, female patient who developed arm sore and 2nd drug dose administration interval too long.    The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, included aendronate (70mg), eye medication, aspirin and vitamin C.   The patient received their first of two planned doses of mRNA-1273 (Batch number: 037K20A) on 19 Jan 2021.   The patient had arm sore for one day. She had an appointment on 05 March 2021 for her second dose administration. The dose interval was 45 days which she had tried to reschedule the 2nd dose but there was no result.   Treatment for the event include one acetaminophen on 19Jan2021.    Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the events was unknown.; Reporter's Comments: This report refers to a case of Inappropriate schedule of Vaccine administration for mRNA-1273 with a reported event of Vaccination site pain. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded for the event of Vaccination site pain.
Approx 3 weeks after the second shot the same leg I had a blood clot in 5 years ago in 2016 had my ankle puffed up with soreness in the calf. I knew it was another blood clot, took almost one week to get a doppler scan and they confirmed that I had another clot. I was put on Eliquis the same day.
My arm started itching on Saturday, Jan. 23 and felt very lumpy. I put lotion on it and decided to try to ignore it and see if it got better. I have been cautious because I had a terrible allergic reaction to Prolia that gave me hives for 8 months and swelled my left leg up. I'm happy that the redness is going down and the lumpiness is gone today on Jan. 25.
Patient had weakness, pain, trouble breathing the next morning after receiving the vaccine. He could not stand. Later that afternoon, he was improving but was taken to the doctor's office. He is improving.
no adverse effect; a 30 year old patient received a dose of PROQUAD; This spontaneous report was received from a pharmacist and refers to a 30-year-old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 02-AUG-2019, the patient was vaccinated with a dose measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot # S002924, expiration date: 28-JUL-2020 (exact dose, site and route of administration were not reported) for prophylaxis (inappropriate age at vaccine administration). There were no known adverse effects reported.
Patient stated he developed rashes around groin area on the same day - Sep 19th (about 4 hours later after getting flu vaccination). He started to take BENADRYL 1 tablet every 4 to 6 hours for rash. And next morning (on 9/20), pt developed more rashes on different areas (on armpits). Per patient, BENADRYL has been helping rashes, but not cleared completely yet. Patient has been receiving flu shot every year (except last year), he is not allergic to eggs. He has finished taking antibiotics (BACTRIM DS) about 2 days before getting vaccinations and had CAT SCAN.
cough; nose congestion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 28-year-old female patient received bnt162b2 (BNT162B2), administration date 11Dec2021 (Batch/Lot number: unknown) at the age of 28 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COUGH (non-serious) with onset 02Jan2022, outcome "unknown", described as "cough"; NASAL CONGESTION (non-serious) with onset 02Jan2022, outcome "unknown", described as "nose congestion".  Additional information: Caller stated she received Pfizer COVID-19 vaccination, first dose on 11Dec2021, however she missed her second dose appointment, and the vaccination site is no longer there. around Sunday 02Jan2022 I started having a little bit of a cough and also kind of nose congestion, can one still get the vaccine while having these symptoms. This case assessed as non-serious by the reporter.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
INCREASING HEADACHE, AND SHORTNESS OF BREATH. Previously frequent bloody nose on 03/30/21, pt is not currently taking any blood thinners, he recently went to the ER on 03/30/21, after the visit the nose bleeding stopped. Pt's wife C/o of edema of the ankles with SOB. C/o severe migraine headaches and back pain. Norco helps the patient with his migraines and pain w/o SEs. Patient has still has SOB on exertion, but it is stable, pt's wife states that he is getting worse, he will c/o of SOB after walking less than half a block. He continues to use 2 L oxygen nasal cannula supplement and his inhalers and nebulizer treatment up to 4-6x a day. No fever and chills. Pt only has occasional cough. When he uses his inhalers, his cough will subside. PATIENT HAS HX OF THROMBOCYTOPENIA, BUT THROMBOCYTOPENIA HAS GOTTEN WORSE AFTER VACCINE.
I had my vaccination on 10/18/2022. I was having symptoms of a head cold on 04/06/2023 to include pressure on my sinuses and ears. I tested COVID-19 Positive on 04/07/2023. I was prescribed Paxlovid on 04/07/2023. I presently feel better on 04/20/2023 and I will test again for COVID-19 on 04/21/2023.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On 12-JUL-2016, the patients were vaccinated with improperly stored doses of GARDASIL 9 (dose, frequency, route of administration and indication were not reported, lot # L017407 with expiration date 15-AUG-2017; K026246 with expiration date 28-JAN-2017). Concomitant therapy was not reported. No adverse effects was reported. Administered vaccines experienced the temperature excursion of 1.9C for 30 minutes, for a cumulative time out of range of 2 hours, 30 minutes on 12-JUL-2016. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
abdominal pain; not felt well; nauseated; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated). At the time of the report, ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's age is in late 20's. Treatment information not provided.
5" x 7" erythemous and swollen patch near injection site on left leg.
Approximately two weeks post vax, pt experienced 6-7 non-vesicular lesions around the injection site. She sought unspecified medical attention. No further information is available.
Patient is complaint about a sharp pain in the vaccinated arm.  She claims she feel shocks from the vaccine site to all the way to the patient's neck.  Patient is planning to see a doctor.
Patient received the 1st dose of Moderna on 1/22/2021; on 2/22/2021, the patient arrived for his 2nd dose and was admisitered the Pfizer vaccine.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information was provided regarding the patient's medical drug and allergy history or concurrent conditions. On 08-NOV-2017, the patient was vaccinated with an expired dose of ZOSTAVAX lot # M030140 and expiration date on 18-AUG-2017, subcutaneously (dose was not reported) for prophylaxis. It was reported that the sterile diluent (MRK) lot # L014262 and expiry date on 17-FEB-2018, was not expired.
Covered in Hives; Significant swelling in face; A spontaneous report (United States) was received from a Consumer concerning a  24Years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like Significant Swelling in Face, Covered in Hives.  The patient's medical history was not reported.  Products known to have been used by the patient, within two weeks prior to the event, included lisdexamfetamine and bupropion.  On 02 Jan 2021 2:00 pm, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch:026-L20A  Exp : 28th May 2021) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On date 02 Jan 2021, the patient experienced the event significant swelling in face.  On date 8th Jan 2021, the patient experienced the event like covered in hives.  The events were treated with diphenhydramine.   Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the events were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Macular papules lesions without pustules over neck, truck, and arms, little on lower extremity. Well dried eschar (scar) @ vaccine site.
Rash all over body the day after receiving the Moderna Covid vaccine 1st dose. Rash got worse as of today. Patient has been taking Benadryl to help relief the symptoms of itching
This spontaneous report was received from a physician refers to a 65 year old female patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On an unknown date the patient was vaccinated with  PNEUMOVAX23 0.5 ml, first dose, once, intramuscular (lot # unspecified) for prophylaxis. The physician reported that an unknown patient experienced an adverse injection site reaction described as a significant localized reaction on the left deltoid, 10 x 11.5 cm, soreness and tenderness in the area, warmth. There was no redness, and swelling/non-pitting edema. The physician provided limited information at the time of the call, but agreed to provide additional information via written correspondence in the future. No further information provided. The outcome of injection site reaction and causality assessment was unknown at the time of this report. Additional information has been requested.
I had blood work yesterday and it's like in the eight hundreds, it was nine hundred and something last month; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID: (086396). The reporter is the patient.  A 74-year-old female patient received palbociclib (IBRANCE), at 125 mg; BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete, Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: BLOOD TEST ABNORMAL (non-serious), outcome "unknown", described as "I had blood work yesterday and it's like in the eight hundreds, it was nine hundred and something last month". Relevant laboratory tests and procedures are available in the appropriate section. The action taken for palbociclib was temporarily withdrawn.  Additional information: Patient stated "I've been on Ibrance for three months now. I had blood work yesterday and it's like in the eight hundreds, it was nine hundred and something last month. So my physician is thinking that it might be the Ibrance. And so I'm off of it until the 21st. I'm supposed to start Ibrance again on the 22nd. So I'm going in on the 21st to get more bloodwork. I'm gonna be off Ibrance for 11 days instead of 7. And I just had my Pfizer covid booster a couple of days before this."  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
In my first vaccine my arm felt like it weighs 500 pounds; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 17Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "In my first vaccine my arm felt like it weighs 500 pounds".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported potential adverse reaction which included not only injection site pain and swelling but pain in entire arm from shoulder to wrist, with pain upon extending arm. She also reported generally not feeling well along with "fever-ish". Recommended for patient to apply ice and take ibuprofen or APAP and we will follow up tomorrow and see if further medical attention is necessary.
24yo F who came in today for vaccines and a few moments after receiving vaccine, while walking down the hall, felt sweaty, flushed, nauseous, and per father, lost consciousness. No fall/head trauma. Father helped her to the grown the hall, felt sweaty, flushed, nauseous, and per father, lost consciousness. No fall/head trauma. Father helped her to the ground. Awoke a few seconds later with normal mental status. Per pt, this has happened to her several times in the past after receiving vaccines or having blood draws. Had been feeling completely fine prior to vaccine today. No wheezing or SOB. No CP or lightheadedness.